astrointestinal stromal tumors (GISTs) are the most common nonepithelial tumors of the gastrointestinal tract (1). Their incidence by anatomic location varies in different studies: 51-70% in the stomach; 25-36% in the small intestine; 5-7% in the colon, rectum, and appendix; and 1-3% in the esophagus. Primary GIST can be found in the omentum, mesentery, or retroperitoneum, unrelated to the tubular gastrointestinal tract, but most in these sites are metastatic from gastric or intestinal primaries (2-7). The distribution of metastases is predictable, with the liver and peritoneum the most common sites (5, 8). The liver is the most common site of metastasis both at presentation and at disease relapse (5). Distant metastasis to other sites, especially the bones and lung, is relatively rare (5, 9). We present radiologic findings in an unusual case of an esophageal GIST with pulmonary and bone lesions.
ply only to neoplasms displaying c-kit (CD117) immunopositivity with very rare exceptions (11) . It is important to mention that normal kit-positive cells in abdominal soft tissues include mast cells present in the wall of the gastrointestinal tract, and the interstitial cells of Cajal (intestinal pacemakers) present around the myenteric plexus (9) . Although the origin of GISTs is not fully understood, their association with the Cajal cells suggests that these cell subsets could represent a multipotential stem-cell-like population, which is the logical candidate for GIST histogenesis (12) .
According to the largest epidemiologic analysis to date, which included 1458 recorded cases (4), as well as studies by Miettinen and Lasota (2) , GIST typically present in adults 40-50 years of age. The most common clinical manifestation for patients with esophageal GISTs is dysphagia (3). Esophageal GISTs are reported up to 25 cm in diameter, and are most commonly located in the distal third of the esophagus (3) . Barium studies of the esophagus may show a smooth intramural mass or a large, ulcerative mass that extends into the esophageal lumen. Distal lesions may extend into shaped air pocket was significantly increased (Fig. 6a) , which was considered to represent volumetric decrease in tumor mass, consistent with clinical improvement in the patient's swallowing function. There was also significant regression of the suspicious pulmonary lesions which were believed to be metastases (Fig. 6b ).
Discussion
GISTs are rare, accounting for 0.1-3.0% of all gastrointestinal neoplasms, and 5.7% of sarcomas (10) . According to a consensus on the diagnosis of GIST, the term "GIST" should ap- the proximal stomach. On CT images, these lesions may be homogeneous or heterogeneous in attenuation. They may contain central areas of low attenuation from hemorrhage, necrosis, or cystic degeneration (13) .
Instead of classifying lesions as either benign or malignant, current guidelines categorize GISTs as low-, intermediate-, and high-risk based on size and mitotic index (14) . In our case, because the tumor size was ≥10 cm, with 5-10 mitoses per 50 HPF, the tumor was considered to be a high-risk GIST.
Metastasis is characteristically the malignant behavior of the GIST. Overall, approximately 10-30% of GISTs exhibit malignant behavior (9, 15) . GIST rarely metastasizes to regional lymph nodes (<10%). It most often metastasizes to the liver (50-60%) and peritoneum (20-43%). Metastasis to the lung and bones is rare (10%), although rectal GIST frequently metastasizes to lung (16) .
Surgical resection of a localized GIST is the mainstay of therapy (17) (18) (19) . Any patient with locally advanced or metastatic disease ("advanced" GIST) should first receive imatinib mesylate (1) .
In conclusion, we presented an unusual case of an approximately 10-cm esophageal GIST with suspicious pulmonary and bone lesions. Only a few reports of esophageal GIST have been published, and, to our knowledge, there have been no reports of the radiologic appearance of an esophageal GIST presenting with pulmonary and bone metastases. This case emphasizes that metastasis should be considered in any case of an esophageal GIST with suspicious pulmonary or bone lesions.
